MedPath
HSA Approval

MEPIVASTESIN INJECTION 30 mg/ml

SIN06179P

MEPIVASTESIN INJECTION 30 mg/ml

MEPIVASTESIN INJECTION 30 mg/ml

May 23, 1991

3M TECHNOLOGIES (S) PTE. LTD.

3M TECHNOLOGIES (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

Registrant3M TECHNOLOGIES (S) PTE. LTD.
Licence Holder3M TECHNOLOGIES (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

BUCCAL

Medical Information

N01BB03

mepivacaine

Manufacturer Information

3 m technologies (s) pte. ltd.

3M Deutschland GmbH

Active Ingredients

MEPIVACAINE HCl

30 mg/ml

Mepivacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEPIVASTESIN INJECTION 30 mg/ml - HSA Approval | MedPath